Form 4: Addus HomeCare Executive Sells Shares to Cover Tax Obligations

Darby Anderson, EVP/Chief Legislative Officer of Addus HomeCare Corp, sold 1,763 shares of common stock at an average price of $85.94 to satisfy tax obligations related to vesting restricted stock awards.

Summary

• On February 23, 2024, Darby Anderson, EVP/Chief Legislative Officer of Addus HomeCare Corp, acquired 5,657 shares of common stock.
• These shares vest in equal installments on February 23, 2025, February 23, 2026, and February 23, 2027, subject to continued service and acceleration upon a change in control.
• On February 26, 2024, Anderson sold 1,763 shares at an average price of $85.94 per share.
• The sale was executed under a pre-established 10b5-1 plan to cover tax obligations arising from the vesting of restricted stock awards.
• Following these transactions, Anderson directly owns 40,754 shares of Addus HomeCare Corp.
• The price reported in Column 4 is a weighted average price, with shares sold in multiple transactions at prices ranging from $85.94 to $85.95, inclusive.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing reflects routine executive stock transactions for tax purposes.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies, often related to compensation and tax planning. The use of 10b5-1 plans allows insiders to sell shares at predetermined times to avoid accusations of insider trading.

Comparison to Industry Standards

• Executive compensation practices, including stock awards and sales, are common across the healthcare industry.
• Companies like LHC Group and Amedisys also utilize stock-based compensation for their executives.
• The vesting schedules and 10b5-1 plans are standard tools for managing executive equity.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the small volume of shares sold.
• The transaction does not directly affect employees, customers, suppliers, or creditors.

Key Dates